Deaths and cardiovascular events in men receiving testosterone

JAMA

Volumn 311, Issue 9, 2014, Pages 961-962

  Morgentaler, Abraham ^a   Traish, Abdulmaged ^b   Kacker, Ravi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DRUG SAFETY; HEART INFARCTION; HORMONAL THERAPY; HUMAN; LETTER; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANDROPAUSE; HUMANS; MALE; MYOCARDIAL INFARCTION; STROKE; TESTOSTERONE;

EID: 84895453192     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.392     Document Type: Letter

References (4)

1. Vigen R, O'Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829-1836.
2. Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011;124(7):578-587.
3. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97(6):2050-2058.
4. Muraleedharan V, Marsh H, Kapoor D, Channer KS, Jones TH. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol. 2013;169(6):725-733.